Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b dose-ranging trial of CP-690,550 vs adalimumab vs placebo in rheumatoid arthritis
2007-002066-35Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tofacitinib in rheumatoid arthritis (RA) (7 arms), sponsored by Pfizer. Started Jul 2007; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-002066-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002066-35.